Lista de obras -

ACE polymorphism and response to electroconvulsive therapy in major depression

artículo científico publicado en 2009

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

artículo científico publicado en 2013

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2007

Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring

artículo científico publicado en 2003

Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy

artículo científico publicado en 2007

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

artículo científico publicado en 2005

Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy

artículo científico publicado en 2008

Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein

artículo científico publicado en 2010

Electroconvulsive therapy in patients with depression and fibromyalgia

scientific article published on 01 August 2004

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

scientific article published on 01 March 2008

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

artículo científico publicado en 2011

One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants

artículo científico publicado en 2004

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

artículo científico publicado en 2011

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2008

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

artículo científico publicado en 2009

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

artículo científico publicado en 2009

The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2005

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

artículo científico publicado en 2010

Lista de obras de

ACE polymorphism and response to electroconvulsive therapy in major depression

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring

Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy

Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein

Electroconvulsive therapy in patients with depression and fibromyalgia

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression